Meinian Onehealth Healthcare Holdings Co., Ltd.

XSEC:002044 Stock Report

Market Cap: CN¥20.5b

Meinian Onehealth Healthcare Holdings Valuation

Is 002044 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 002044 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
CN¥6.50
Fair Value
18.7% undervalued intrinsic discount
3
Number of Analysts

Below Fair Value: 002044 (CN¥5.28) is trading below our estimate of fair value (CN¥6.5)

Significantly Below Fair Value: 002044 is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 002044?

Key metric: As 002044 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 002044. This is calculated by dividing 002044's market cap by their current earnings.
What is 002044's PE Ratio?
PE Ratio70x
EarningsCN¥293.52m
Market CapCN¥20.54b

Price to Earnings Ratio vs Peers

How does 002044's PE Ratio compare to its peers?

The above table shows the PE ratio for 002044 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average31.8x
600763 Topchoice Medical
36.3x9.28%CN¥18.6b
600682 Nanjing Xinjiekou Department Store
39.3xn/aCN¥9.0b
300962 Zhongjin Irradiation
40xn/aCN¥4.2b
600511 China National Medicines
11.6x7.94%CN¥22.9b
002044 Meinian Onehealth Healthcare Holdings
70.4x41.54%CN¥20.7b

Price-To-Earnings vs Peers: 002044 is expensive based on its Price-To-Earnings Ratio (70x) compared to the peer average (31.8x).

Price to Earnings Ratio vs Industry

How does 002044's PE Ratio compare vs other companies in the CN Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
002044 70.0xIndustry Avg. 31.6xNo. of Companies4PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 002044 is expensive based on its Price-To-Earnings Ratio (70x) compared to the CN Healthcare industry average (31.6x).

Price to Earnings Ratio vs Fair Ratio

What is 002044's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

002044 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio70x
Fair PE Ratio46.5x

Price-To-Earnings vs Fair Ratio: 002044 is expensive based on its Price-To-Earnings Ratio (70x) compared to the estimated Fair Price-To-Earnings Ratio (46.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 002044 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥5.28
CN¥6.42
+21.59%
10.53%CN¥7.36CN¥5.80n/a3
May ’26CN¥5.34
CN¥5.82
+8.99%
23.81%CN¥7.36CN¥4.00n/a3
Apr ’26CN¥5.64
CN¥5.82
+3.19%
23.81%CN¥7.36CN¥4.00n/a3
Mar ’26CN¥6.14
CN¥5.82
-5.21%
23.81%CN¥7.36CN¥4.00n/a3
Feb ’26CN¥4.36
CN¥5.82
+33.49%
23.81%CN¥7.36CN¥4.00n/a3
Jan ’26CN¥4.59
CN¥5.82
+26.80%
23.81%CN¥7.36CN¥4.00n/a3
Dec ’25CN¥4.92
CN¥5.82
+18.29%
23.81%CN¥7.36CN¥4.00n/a3
Nov ’25CN¥4.69
CN¥5.53
+17.84%
23.71%CN¥7.20CN¥4.00n/a3
Oct ’25CN¥4.33
CN¥5.53
+27.64%
23.71%CN¥7.20CN¥4.00n/a3
Sep ’25CN¥3.47
CN¥6.88
+98.17%
9.12%CN¥7.43CN¥6.00n/a3
Aug ’25CN¥3.70
CN¥6.88
+85.86%
9.12%CN¥7.43CN¥6.00n/a3
Jul ’25CN¥3.77
CN¥6.88
+82.41%
9.12%CN¥7.43CN¥6.00n/a3
Jun ’25CN¥4.19
CN¥6.88
+64.12%
9.12%CN¥7.43CN¥6.00n/a3
May ’25CN¥4.42
CN¥7.76
+75.64%
5.15%CN¥8.09CN¥7.20CN¥5.343
Apr ’25CN¥5.07
CN¥8.20
+61.67%
2.65%CN¥8.50CN¥8.00CN¥5.643
Mar ’25CN¥5.63
CN¥8.20
+45.59%
2.65%CN¥8.50CN¥8.00CN¥6.143
Feb ’25CN¥4.98
CN¥8.20
+64.59%
2.65%CN¥8.50CN¥8.00CN¥4.363
Jan ’25CN¥6.01
CN¥8.43
+40.32%
3.91%CN¥8.80CN¥8.00CN¥4.593
Dec ’24CN¥6.18
CN¥8.56
+38.45%
4.16%CN¥8.93CN¥8.00CN¥4.924
Nov ’24CN¥6.21
CN¥8.56
+37.78%
4.16%CN¥8.93CN¥8.00CN¥4.694
Oct ’24CN¥6.80
CN¥8.48
+24.63%
4.46%CN¥8.93CN¥8.00CN¥4.333
Sep ’24CN¥6.83
CN¥8.48
+24.08%
4.46%CN¥8.93CN¥8.00CN¥3.473
Aug ’24CN¥7.18
CN¥8.48
+18.04%
4.46%CN¥8.93CN¥8.00CN¥3.703
Jul ’24CN¥7.11
CN¥7.96
+11.99%
12.09%CN¥8.93CN¥7.00CN¥3.772
Jun ’24CN¥6.48
CN¥7.96
+22.88%
12.09%CN¥8.93CN¥7.00CN¥4.192
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
CN¥6.42
Fair Value
17.8% undervalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/21 16:58
End of Day Share Price 2025/05/21 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Meinian Onehealth Healthcare Holdings Co., Ltd. is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Jin ZhangChina International Capital Corporation Limited
Qianyi LiChina International Capital Corporation Limited